Article info

Original research
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer

Authors

  • Julie Lecuelle Platform of Transfer in Biological Oncology, Georges-Francois Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, FranceUMR INSERM 1231, Dijon, Bourgogne-Franche-Comté, FranceGenomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, FranceUniversity of Burgundy-Franche Comté, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Laure Favier Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Cléa Fraisse Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Aurélie Lagrange Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Coureche Kaderbhai Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Romain Boidot Department of Biopathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Sandy Chevrier Department of Biopathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Philippe Joubert Department of Pathology, Quebec Heart and Lung Institute Research Center, Quebec City, Quebec, Canada PubMed articlesGoogle scholar articles
  • Bertrand Routy Department of Medicine Montréal, Division of Oncology, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaDivision of Hematology-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Quebec City, Quebec, Canada PubMed articlesGoogle scholar articles
  • Caroline Truntzer Platform of Transfer in Biological Oncology, Georges-Francois Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, FranceUMR INSERM 1231, Dijon, Bourgogne-Franche-Comté, FranceGenomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, FranceUniversity of Burgundy-Franche Comté, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  • Francois Ghiringhelli Platform of Transfer in Biological Oncology, Georges-Francois Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, FranceUMR INSERM 1231, Dijon, Bourgogne-Franche-Comté, FranceGenomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, FranceUniversity of Burgundy-Franche Comté, Dijon, Bourgogne-Franche-Comté, FranceDepartmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Francois Ghiringhelli; fghiringhelli{at}cgfl.fr
View Full Text

Citation

Lecuelle J, Favier L, Fraisse C, et al
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer

Publication history

  • Accepted February 5, 2022
  • First published March 11, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.